Mohamad M. Adada

Mohamad M. Adada

Auto-generated profile, based on publicly available information

Mohamad M. Adada

T Cell Engineering, Mayo Clinic, Rochester, MN

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2016 in Chemistry and Physics of Lipids
Verified
Journal Article
Closed access
MAMohamad Adada
Mohamad Adada
CLChiara Luberto
Chiara Luberto
DCDaniel Canals
Daniel Canals

24 July 2013 in The FEBS Journal
Verified
Journal Article
Open access
PDF file
MAMohamad Adada
Mohamad Adada
DCDaniel Canals
Daniel Canals
YHYusuf A. Hannun
Yusuf A. Hannun
LOLina M. Obeid
Lina M. Obeid
Sphingosine‐1‐phosphate (S1P) is a potent bioactive sphingolipid involved in cell proliferation, angiogenesis, inflammation and malignant transformation among other functions. S1P acts either directly on intracellular targets or activates G protein‐coupled receptors, specifically five S1P receptors (S1PRs). The identified S1PRs differ in cellular and tissue distribution, and each is coupled to specific G proteins, which mediate unique functions. Here, we describe functional characteristics of all five receptors, emphasizing S1PR2, which is critical in the immune, nervous, metabolic, cardiovascular, musculoskeletal, and renal systems. This review also describes the role of this receptor in tumor growth and metastasis and suggests potential therapeutic avenues that exploit S1PR2.

1 October 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MHMar&Iacutea José Hernández-Corbacho
Mar&Iacutea José Hernández-Corbacho
DCDaniel Canals
Daniel Canals
MAMohamad M. Adada
Mohamad M. Adada
MLMengling Liu
Mengling Liu
CSCan E. Senkal
Can E. Senkal
LOLina M. Obeid
Lina M. Obeid
Ceramide synthases (CerS1-CerS6), which catalyze the N-acylation of the (dihydro)sphingosine backbone to produce (dihydro)ceramide in both the de novo and the salvage or recycling pathway of ceramide generation, have been implicated in the control of programmed cell death. However, the regulation of the de novo pathway compared with the salvage pathway is not fully understood. In the current study, we have found that late accumulation of multiple ceramide and dihydroceramide species in MCF-7 cells treated with tumor necrosis factor alpha (TNFα) occurred by upregulation of both pathways of ceramide synthesis. Nevertheless, fumonisin B1 but not myriocin was able to protect from TNFα-induced cell death, suggesting that ceramide synthase activity is crucial for the progression of cell death, and that the pool of ceramide involved derives from the salvage pathway rather than de novo biosynthesis. Furthermore, compared to control cells, TNFα-treated cells exhibited reduced focal adhesion kinase (FAK) and subsequent plasma membrane permeabilization, which was blocked exclusively by fumonisin B1. In addition, exogenously added C6-Ceramide mimicked the effects of TNFα that lead to cell death, which were inhibited by fumonisin B1. Knockdown of individual ceramide synthases identified CerS6, and its product C16-ceramide, as the ceramide synthase isoform essential for the regulation of cell death. In summary, our data suggest a novel role for CerS6/C16-ceramide as an upstream effector of the loss of focal adhesion protein and plasma membrane permeabilization, via the activation of caspase-7, and identifies the salvage pathway as the critical mechanism of ceramide generation that controls cell death.

7 August 2017 in Oncogene
Verified
Journal Article
Open access
PDF file
MWM Wada
M Wada
DCD Canals
D Canals
MAM Adada
M Adada
NCN Coant
N Coant
MSMohamed Salama
Mohamed Salama
YHYusuf Hannun
Yusuf Hannun
The protein p38 mitogen-activated protein kinase (MAPK) delta isoform (p38δ) is a poorly studied member of the MAPK family. Data analysis from The Cancer Genome Atlas database revealed that p38δ is highly expressed in all types of human breast cancers. Using a human breast cancer tissue array, we confirmed elevation in cancer tissue. The breast cancer mouse model, MMTV-PyMT (PyMT), developed breast tumors with lung metastasis; however, mice deleted in p38δ (PyMT/p38δ−/−) exhibited delayed primary tumor formation and highly reduced lung metastatic burden. At the cellular level, we demonstrate that targeting of p38δ in breast cancer cells, MCF-7 and MDA-MB-231 resulted in a reduced rate of cell proliferation. In addition, cells lacking p38δ also displayed an increased cell–matrix adhesion and reduced cell detachment. This effect on cell adhesion was molecularly supported by the regulation of the focal adhesion kinase by p38δ in the human breast cell lines. These studies define a previously unappreciated role for p38δ in breast cancer development and evolution by regulating tumor growth and altering metastatic properties. This study proposes MAPK p38δ protein as a key factor in breast cancer. Lack of p38δ resulted in reduced primary tumor size and blocked the metastatic potential to the lungs.

9 January 2013 in Biochemical Journal
Verified
Journal Article
Open access
PDF file
KGK. Alexa Orr Gandy
K. Alexa Orr Gandy
DCDaniel Canals
Daniel Canals
MAMohamad Adada
Mohamad Adada
MWMasayuki Wada
Masayuki Wada
PRPatrick Roddy
Patrick Roddy
LOLina M. Obeid
Lina M. Obeid
Previously we demonstrated that the sphingolipids ceramide and S1P (sphingosine 1-phosphate) regulate phosphorylation of the ERM (ezrin/radixin/moesin) family of cytoskeletal proteins [Canals, Jenkins, Roddy, Hernande-Corbacho, Obeid and Hannun (2010) J. Biol. Chem. 285, 32476–3285]. In the present article, we show that exogenously applied or endogenously generated S1P (in a sphingosine kinase-dependent manner) results in significant increases in phosphorylation of ERM proteins as well as filopodia formation. Using phosphomimetic and non-phosphorylatable ezrin mutants, we show that the S1P-induced cytoskeletal protrusions are dependent on ERM phosphorylation. Employing various pharmacological S1PR (S1P receptor) agonists and antagonists, along with siRNA (small interfering RNA) techniques and genetic knockout approaches, we identify the S1PR2 as the specific and necessary receptor to induce phosphorylation of ERM proteins and subsequent filopodia formation. Taken together, the results demonstrate a novel mechanism by which S1P regulates cellular architecture that requires S1PR2 and subsequent phosphorylation of ERM proteins.

24 July 2015 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
MAMohamad M. Adada
Mohamad M. Adada
DCDaniel Canals
Daniel Canals
NJNara Jeong
Nara Jeong
AKAshwin D. Kelkar
Ashwin D. Kelkar
MHMaria Hernandez‐Corbacho
Maria Hernandez‐Corbacho
LOLina M. Obeid
Lina M. Obeid
The bioactive sphingolipid sphingosine‐1‐phosphate (S1P) mediates cellular proliferation, mitogenesis, inflammation, and angiogenesis. These biologies are mediated through S1P binding to specific GPCRs [sphingosine‐1‐phosphate receptor (S1PR)1‐5] and some other less well‐characterized intracellular targets. Ezrinradixin‐moesin (ERM) proteins, a family of adaptor molecules linking the cortical actin cytoskeleton to the plasma membrane, are emerging as critical regulators of cancer invasion via regulation of cell morphology and motility. Recently, we identified S1P as an acute ERM activator ( via phosphorylation) through its action on S1PR2. In this work, we dissect the mechanism of S1P generation downstream of epidermal growth factor (EGF) leading to ERM phosphorylation and cancer invasion. Using pharmacologic inhibitors, small interfering RNA technologies, and genetic approaches, we demonstrate that sphingosine kinase (SK) 2, and not SK1, is essential and sufficient in EGF‐mediated ERM phosphorylation in HeLa cells. In fact, knocking down SK2 decreased ERM activation 2.5‐fold. Furthermore, we provide evidence that SK2 is necessary to mediate EGF‐induced invasion. In addition, overexpressing SK2 causes a 2‐fold increase in HeLa cell invasion. Surprisingly, and for the first time, we find that this event, although dependent on S1PR2 activation, does not generate and does not require extracellular S1P secretion, therefore introducing a potential novel model of autocrine/intracrine action of S1P that still involves its GPCRs. These results define new mechanistic insights for EGF‐mediated invasion and novel actions of SK2, therefore setting the stage for novel targets in the treatment of growth factor‐driven malignancies.—Adada, M. M., Canals, D., Jeong, N., Kelkar, A. D., Hernandez‐Corbacho, M., Pulkoski‐Gross, M. J., Donaldson, J. C., Hannun, Y. A., Obeid, L. M. Intracellular sphingosine kinase 2‐derived sphingosine‐1‐phosphate mediates epidermal growth factor‐induced ezrin‐radixin‐moesin phosphorylation and cancer cell invasion. FASEB J. 29, 4654‐4669 (2015). www.fasebj.org